文献速递肾癌与肾肿瘤

简化PADUA肾脏(SPARE)肾测量系统:一种适用于部分肾切除术的肾实质肿瘤新分类

The Simplified PADUA REnal (SPARE) nephrometry system: a novel classification of parenchymal renal tumours suitable for partial nephrectomy.
PubMed 文献 · BJU Int · 2019-05-07

本研究基于5家三级学术转诊中心2014年1月至2016年12月531例接受部分肾切除术的肾肿瘤患者临床记录,简化原始PADUA分类,构建仅含4个变量的SPARE系统。SPARE预测总体并发症的AUC为0.657,原始PADUA为0.664;加入肿瘤接触表面积(CSA)未提高两种系统的预测准确性。SPARE是术后总体并发症的独立预测因子(OR 1.2,95%CI 1.1-1.3)。

要点

  • SPARE系统仅含4个变量:边缘位置、肾窦侵犯、外生率、肿瘤尺寸。
  • SPARE预测总体并发症的AUC为0.657,原始PADUA为0.664,两者性能相当。
  • 加入肿瘤CSA未提高原始PADUA(AUC 0.661)或SPARE(AUC 0.658)的预测准确性。

核心结论

  • SPARE评分仅含4个变量而非原始6个,预测总体并发症的准确性与原始PADUA相似。
  • 加入肿瘤CSA与预后准确性提高无关。
  • SPARE系统可替代原始PADUA评分评估适合部分肾切除术的肿瘤复杂性。

研究设计与样本

  • 回顾性分析5家三级学术转诊中心2014年1月至2016年12月531例接受部分肾切除术(开放、腹腔镜和机器人辅助)的肾肿瘤患者临床记录。
  • 采用二元逻辑回归分析PADUA分类中各变量预测总体并发症的能力,剔除无统计学意义的变量形成SPARE分类。
  • 另生成加入肿瘤CSA的两种模型,用受试者工作特征曲线分析比较四种模型预测总体并发症的能力。

主要发现

  • SPARE肾测量评分系统包括边缘位置、肾窦侵犯、外生率和肿瘤尺寸。
  • SPARE与原始PADUA预测总体并发症的AUC分别为0.657 vs 0.664。
  • 原始PADUA加入肿瘤CSA后AUC为0.661,SPARE加入肿瘤CSA后AUC为0.658。
  • SPARE系统是术后总体并发症的独立预测因子(OR 1.2,95%CI 1.1-1.3)。
  • 年龄(P < 0.001)、体重指数(P < 0.001)、Charlson合并症指数(P = 0.02)、术前eGFR(P < 0.001)和肿瘤CSA(P = 0.005)是eGFR绝对变化(ACE)的独立预测因子。

临床怎么用

  • 作者认为SPARE系统可替代原始PADUA评分评估适合部分肾切除术的肿瘤复杂性。

局限性

  • 局限性包括回顾性设计。
  • 缺乏中心影像学审查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To simplify the original Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) classification of renal tumours, generating a new system able to predict equally or better the risk of overall complications in patients undergoing partial nephrectomy (PN); and to test if the addition of the contact surface area (CSA) parameter improves the accuracy of the original PADUA and new Simplified PADUA REnal (SPARE) nephrometry classification systems. PATIENTS AND METHODS: We analysed the clinical records of 531 patients who underwent PN (open, laparoscopic and robot-assisted) for renal tumours at five tertiary academic referral centres from January 2014 to December 2016. The ability of each variable included in the PADUA classification to predict overall complications was tested using binary logistic regression analysis. The variables that were not statistically significant were excluded from the SPARE classification. In addition to the original PADUA and SPARE systems, another two models were generated adding tumour CSA. Receiver operating characteristic curve analysis was used to compare the ability of the four different models to predict overall complications. Binary logistic regression was used to perform both univariable and multivariable analyses looking for predictors of postoperative complications. Linear regression analysis was used to identify independent predictors of absolute change in estimated glomerular filtration rate (eGFR; ACE). RESULTS: The SPARE nephrometry score system including: (i) rim location, (ii) renal sinus involvement, (iii) exophytic rate, and (iv) tumour dimension; showed equal performance in comparison with the original PADUA score (area under the curve [AUC] 0.657 vs 0.664). Adding tumour CSA to the original PADUA (AUC 0.661) or to the SPARE (AUC 0.658) scores did not increase the accuracy of either system to predict overall complications. The SPARE system (odds ratio 1.2, 95% confidence interval 1.1-1.3) was an independent predictor of postoperative overall complications. Age (P < 0.001), body mass index (P < 0.001), Charlson Comorbidity Index (P = 0.02), preoperative eGFR (P < 0.001), and tumour CSA (P = 0.005) were independent predictors of ACE. Limitations include the retrospective design and the lack of central imaging review. CONCLUSIONS: The new SPARE score is comprised of only four variables instead of the original six and its accuracy to predict overall complications is similar to that of the original PADUA score. Addition of tumour CSA was not associated with an increase in prognostic accuracy. The SPARE system could replace the original PADUA score to evaluate the complexity of tumours suitable for PN.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Ficarra V, Porpiglia F, Crestani A, et al. The Simplified PADUA REnal (SPARE) nephrometry system: a novel classification of parenchymal renal tumours suitable for partial nephrectomy. BJU Int. 2019. PMID: 30963680. doi:10.1111/bju.14772

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。